Accès ouvert

Author Correction: Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study

Article scientifique 2018 Anglais

Résumé

In the original version of the published article, line three of the third paragraph of the methods stated “Excluding patients with micrometastatic disease, the 5-year BCSM for patients with Recurrence Score results <18 and 1–3 positive nodes (n = 2,617) was 1.3% (95% CI, 0.6–2.9%).” To improve clarity this statement has been replaced with “Excluding patients with micrometastatic disease, there were 2,617 patients with 1–3 positive nodes. Of these, 1,487 also had Recurrence Score results <18 with 5-year BCSM of 1.3% (95% CI, 0.6–2.9%).” The original version of the published article also contained an error in the second sentence of the Figure 2 legend describing the mutation status of the patient population examined. The sentence in the original published version of the article stated “Patients with HR+, HER2-positive, node-negative…” this has been changed to “Patients with HR+, HER2-negative, node-negative…”. This has been corrected in the PDF and HTML versions of this paper.

Citer ce document

Petkov, V., Miller, D., Howlader, N., Gliner, N., Howe, W., Schussler, N., Cronin, K., Baehner, F., Cress, R., Deapen, D., Glaser, S., Hernandez, B., Lynch, C., Mueller, L., Schwartz, A., Schwartz, S., Stroup, A., Sweeney, C., Tucker, T., Ward, K., Wiggins, C., Wu, X., Penberthy, L., Shak, S. (2018). Author Correction: Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study. https://doi.org/10.1038/s41523-018-0069-3

Accès au document

Voir sur le dépôt source

Ce document est hébergé sur son dépôt institutionnel d'origine.

Statistiques

Consultations : 2

Téléchargements : 0